Safety · 2026-10-21
San Francisco identifies MGM-15 in fatal overdose and product packaging
Source: San Francisco Department of Public Health
Why it matters
San Francisco health officials reported a fatal overdose involving MGM-15, a semi-synthetic kratom-derived opioid, and confirmed the substance in associated product packaging. The alert concerns a specific derivative and mislabeled product, not a measured risk estimate for natural kratom leaf.
The big picture
The October 21 advisory describes an adult who died in late September and the city’s first known overdose case involving MGM-15. Officials said the product was marketed as cat’s claw and differed from brands identified in Utah and Washington. This local toxicology finding is distinct from those earlier warnings.
Key findings
- The San Francisco medical examiner detected MGM-15 in an adult overdose decedent who died in late September, according to the health department’s October 21 announcement.
- Forensic testing confirmed MGM-15 in both the decedent and the packaging of the consumed product, officials reported. The announcement does not provide a dose, concentration or complete toxicology panel.
- The identified product was branded Script botanicals x Maui labs and marketed as uncaria tomentosa, or cat’s claw. Officials said its packaging did not mention kratom or 7-hydroxymitragynine.
- The department describes MGM-15 as a semi-synthetic kratom-derived opioid without an approved medical use. Its identification does not establish that unmodified leaf has the same composition or risk.
- Officials recommend administering naloxone and calling 911 for a suspected overdose. The announcement is a case-based safety alert, without a user denominator or evidence establishing how often comparable events occur.
What they say
The San Francisco Department of Public Health says its medical examiner continues testing for emerging substances and shares results with the department to guide public-health responses.
Bottom line
San Francisco’s alert links a fatal overdose and associated cat’s-claw-labeled packaging to MGM-15; it does not quantify the risk of natural-leaf kratom.